State Street’s Marker Therapeutics MRKR Stock Holding History

State Street’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.8K	Hold	20,948	–	–	﹤0.01%	4101
2026 Q1	$27.2K	Hold	20,948	–	–	﹤0.01%	4192
2025 Q4	$31.2K	Hold	20,948	–	–	﹤0.01%	4208
2025 Q3	$18.7K	Hold	20,948	–	–	﹤0.01%	4251
2025 Q2	$32K	Hold	20,948	–	–	﹤0.01%	4160
2025 Q1	$25.8K	Hold	20,948	–	–	﹤0.01%	4180
2024 Q4	$65.1K	Hold	20,948	–	–	﹤0.01%	4070
2024 Q3	$59.1K	Hold	20,948	–	–	﹤0.01%	4071
2024 Q2	$114K	Buy	20,948 +1,200	+6%	+$5.1K	﹤0.01%	3970
2024 Q1	$84.9K	Hold	19,748	–	–	﹤0.01%	4056
2023 Q4	$109K	Hold	19,748	–	–	﹤0.01%	4040
2023 Q3	$90.8K	Buy	19,748 +1,000	+5%	+$5.59K	﹤0.01%	4134
2023 Q2	$58.1K	Hold	18,748	–	–	﹤0.01%	4383
2023 Q1	$13.3K	Hold	18,748	–	–	﹤0.01%	4728
2022 Q4	$49.4K	Hold	18,748	–	–	﹤0.01%	4561
2022 Q3	$69K	Hold	18,748	–	–	﹤0.01%	4580
2022 Q2	$62K	Sell	18,748 -200	-1%	-$665	﹤0.01%	4679
2022 Q1	$83K	Sell	18,948 -717	-4%	-$4.1K	﹤0.01%	4693
2021 Q4	$187K	Hold	19,665	–	–	﹤0.01%	4376
2021 Q3	$332K	Buy	19,665 +390	+2%	+$7.99K	﹤0.01%	4138
2021 Q2	$538K	Sell	19,275 -38,348	-67%	-$1.01M	﹤0.01%	3829
2021 Q1	$1.29M	Buy	57,623 +3,563	+7%	+$81.5K	﹤0.01%	3572
2020 Q4	$784K	Sell	54,060 -2,190	-4%	-$34K	﹤0.01%	3595
2020 Q3	$844K	Buy	56,250 +3,283	+6%	+$59.9K	﹤0.01%	3484
2020 Q2	$1.1M	Sell	52,967 -5,101	-9%	-$112K	﹤0.01%	3396
2020 Q1	$1.1M	Buy	58,068 +1,068	+2%	+$27.2K	﹤0.01%	3279
2019 Q4	$1.64M	Buy	57,000 +2,550	+5%	+$92.8K	﹤0.01%	3308
2019 Q3	$2.78M	Buy	54,450 +4,692	+9%	+$277K	﹤0.01%	3094
2019 Q2	$3.94M	Buy	49,758 +47,638	+2,247%	+$2.83M	﹤0.01%	2955
2019 Q1	$140K	Hold	2,120	–	–	﹤0.01%	3609
2018 Q4	$118K	Buy	+2,120	New	+$155K	﹤0.01%	3622
2018 Q3	–	Sell	-2,030	Closed	-$191K	–	3790
2018 Q2	$191K	Buy	+2,030	New	+$104K	﹤0.01%	3573

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

State Street's MRKR Position: Q2 2026 in Review

State Street held its Marker Therapeutics (MRKR) position steady in Q2 2026 at 20,948 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4101.

State Street first reported a position in MRKR in Q2 2018 and has held it in 32 quarters since. The position peaked at $3.94M in Q2 2019. 35 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

State Street held 20,948 shares of Marker Therapeutics worth $30.8K as of Q2 2026.
State Street left its Marker Therapeutics share count unchanged in Q2 2026.
Marker Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4101 holding.
State Street first reported a position in Marker Therapeutics in Q2 2018 and has held it in 32 quarters since.
State Street's Marker Therapeutics position peaked at $3.94M in Q2 2019.
35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.